Derek J. Rosario

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · New England Journal of Medicine · 2016 · 2.6K citations · Full text

Medicine, Oncology, Urology +13

Patient-Reported Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Jenny Donovan, Freddie C. Hamdy, J. Athene Lane et al. · New England Journal of Medicine · 2016 · 1.3K citations · Full text

Medicine, Surgery, Urology +14

Fifteen-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Prostate Cancer

Freddie C. Hamdy, Jenny Donovan, J. Athene Lane et al. · New England Journal of Medicine · 2023 · 751 citations · Full text

Medicine, Oncology, Urology +12

Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised controlled trial

Abdel-Rahmène Azzouzi, S. Vincendeau, Éric Barret et al. · The Lancet Oncology · 2016 · 330 citations

Medicine, Oncology, Pharmacology +15

Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer

James W.F. Catto, Saiful Miah, Helen C. Owen et al. · Cancer Research · 2009 · 328 citations · Full text

Medicine, Cancer Biology, Oncology +17